Prelude Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-24,485
| Closed | -$430K | – | 2119 |
|
|
2021
Q3 | $430K | Buy |
+24,485
| New | +$430K | 0.01% | 726 |
|
|
2017
Q3 | – | Sell |
-29,700
| Closed | -$131K | – | 1858 |
|
|
2017
Q2 | $131K | Buy |
29,700
+6,200
| +26% | +$27.3K | 0.01% | 639 |
|
|
2017
Q1 | $145K | Hold |
23,500
| – | – | 0.01% | 628 |
|
|
2016
Q4 | $133K | Buy |
23,500
+23,100
| +5,775% | +$131K | 0.02% | 700 |
|
|
2016
Q3 | $6K | Buy |
400
+200
| +100% | +$3K | ﹤0.01% | 1409 |
|
|
2016
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 1461 |
|